Sionna Therapeutics, Inc. Common Stock
SION • NASDAQ
Sionna Therapeutics, Inc. Common Stock is a publicly traded company trading on NASDAQ, led by CEO Michael Cloonan, with a market cap of $1.7B.
Market Cap$1.7B
CEOMichael Cloonan
CountryUnited States of America
Next EarningsMay 11, 2026 · In 4 weeksQ1 2026
Financials
Sionna Therapeutics, Inc. Common Stock FAQ
Common questions about Sionna Therapeutics, Inc. Common Stock
Sionna Therapeutics, Inc. Common Stock is scheduled to report earnings for Q1 2026 on May 11, 2026.